Johnson & Johnson (NYSE:JNJ) engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

It will report its Q1 2025 earnings on April 15. Wall Street analysts expect the company to post EPS of $2.59, down from $2.71 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $21.60 billion, up from $21.38 billion a year earlier.

Don't Miss:

• Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!
• Many are using retirement income calculators to check if they’re on pace — here’s a breakdown on what’s behind this formula.

The 52-week range of Johnson & Johnson stock price was $140.68 to $169.99.

Johnson & Johnson's dividend yield is 3.27%. It paid $4.96 per share in dividends during the last 12 months.

The Latest On Johnson & Johnson

On Jan. 22, the company announced its Q4 2024 earnings, posting adjusted EPS of $2.04, beating the consensus of $2.01, as reported by Benzinga. The pharmaceutical giant reported sales of $22.52 billion, up 5.3% year-over-year and beating the consensus of $22.44 billion.

The company expects full-year 2025 sales in the range of $90.9 billion to $91.7 billion, compared to the consensus of $90.99 billion. Full-year adjusted EPS is seen at $10.75 to $10.95, compared to the consensus estimate of $10.59.

Check out this article by Benzinga for 13 analysts' insights on Johnson & Johnson.

Trending: It’s no wonder Jeff Bezos holds over $250 million in art — this alternative asset has outpaced the S&P 500 since 1995, delivering an average annual return of 11.4%. Here’s how everyday investors are getting started.

How Can You Earn $100 Per Month As A Johnson & Johnson Investor?

If you want to make $100 per month — $1,200 annually — from Johnson & Johnson dividends, your investment value needs to be approximately $36,697, which is around 242 shares at $151.73 each. 

Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (3.27% in this case). So, $1,200 / 0.0327 = $36,697 to generate an income of $100 per month.

You can calculate the dividend yield by dividing the annual dividend payments by the current price of the stock.

The dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling basis.

See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.60 per share now.

For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40).

In summary, income-focused investors may find Johnson & Johnson stock an attractive option for making a steady income of $100 per month by owning 242 shares of stock. There may be more upside to come as investors benefit from the company's consistent dividend hikes. Johnson & Johnson has raised its dividend consecutively for the last 62 years. 

Read Next:

• With shares starting at $1.52, this could be your chance to invest in the future of healthcare.
• Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!

Image: Shutterstock

Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.

Get the latest stock analysis from Benzinga?

• JOHNSON & JOHNSON (JNJ): Free Stock Analysis Report

This article How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock originally appeared on Benzinga.com

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.